Proton beam takes aim at returning throat cancer
NCT ID NCT07412314
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a precise type of radiation called proton therapy for people whose nasopharyngeal cancer has come back. The goal is to see if it can control the cancer while causing fewer severe side effects than standard treatments. About 52 adults with recurrent, non-spreading cancer will take part. Researchers will track serious complications and how long participants live.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangzhou Concord Cancer Center
RECRUITINGGuangzhou, Guangdong, China
-
Guangzhou concord cancer center
RECRUITINGGuanzhou, Guangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy plus chemo shows promise for Tough-to-Treat nasopharyngeal cancer
- Immunotherapy boost may improve outcomes in returning throat cancer
- New surgery technique could improve survival in recurrent throat cancer
- Drug combo targets rare cancers in early trial
- Immune booster: donor NK cells aim to cut cancer recurrence
- Double immunotherapy may keep nasopharyngeal cancer at bay